Selected article for: "asymptomatic patient and RNA clearance"
Author: Ma, Shu‐Qing; Zhang, Jing; Wang, Yu‐Shan; Xia, Jun; Liu, Peng; Luo, Hong; Wang, Ming‐Yi
Title: Glucocorticoid therapy delays the clearance of SARS‐CoV‐2 RNA in an asymptomatic COVID‐19 patient
  • Cord-id: 4j4bdh0q
  • Document date: 2020_5_29
    • ID: 4j4bdh0q
    Snippet: The outbreak of severe acute respiratory syndrome‐related coronavirus 2 (SARS‐CoV‐2) started in Wuhan China, has become a global health concern. At present, glucocorticoid therapy is one of the most typically controversial treatments with COVID‐19 patients. Here, we reported an asymptomatic COVID‐19 patient with persistent positive detection of SARS‐CoV‐2 for 3 weeks and proposed that glucocorticoid therapy delays the clearance of SARS‐CoV‐2 RNA. Therefore, more attention must
    Document: The outbreak of severe acute respiratory syndrome‐related coronavirus 2 (SARS‐CoV‐2) started in Wuhan China, has become a global health concern. At present, glucocorticoid therapy is one of the most typically controversial treatments with COVID‐19 patients. Here, we reported an asymptomatic COVID‐19 patient with persistent positive detection of SARS‐CoV‐2 for 3 weeks and proposed that glucocorticoid therapy delays the clearance of SARS‐CoV‐2 RNA. Therefore, more attention must be paid to the COVID‐19 patients receiving glucocorticoid therapy. This article is protected by copyright. All rights reserved.

    Search related documents:
    Co phrase search for related documents, hyperlinks ordered by date